To evaluate orthopedic devices in pathological bone, an experimental study was performed by implanting Titanium (Ti) and Hydroxyapatite (HA) rods in normal and osteopenic bone. Twenty-four rats were used: 12 were left intact (Control: C) while the other 12 were ovariectomized (OVX). After 4 months all the animals were submitted to the implant of Ti or HA in the left femoral condyle (Ti-C, HA-C, Ti-OVX, HA-OVX). Two months later the animals were sacrificed for histomorphometric, ultrastructural and microanalytic studies. Our results show a significant difference between the Affinity Index (A.I.) of HA-C and Ti-C (77.0 ± 7.4 vs 61.2 ± 9.7) (p < 0.05). No significant differences were observed between the osteointegration of Ti-C and Ti-OVX (61.2 ± 9.7 vs 48.2 ± 6.7). Significant differences also exist between the osteointegration of HA-C and HA-OVX (77.0 ± 7.4 vs 57.6 ± 11.5) (p < 0.01). Microanalysis shows some modifications in Sulphur (S) concentration at the bone/biomaterial interface of the Ti-OVX group. Therefore our results confirmed the importance of biomaterials characteristics and of bone quality in osteointegration processes.
BedaniP.L., OrzincoloC., StorariA.. Clinical and radiological features of bone disease in long-term (15 or more years) hemodialysis patients.Int J Artif Organs1993; 16(10): 704–10.
6.
BoccalatteM., PratesiG., CalabreseG., BignazziA., GonellaM.. Amyloid bone disease and highly permeable synthetic membranes.Int J Artif Organs1994; 17(4): 203–8.
7.
EpsteinS., ShaneE., BilezikianJ.P.. Organ transplantation and osteoporosis.Curr Opin Rheumatol1995, 7(3): 255–61.
8.
GrotzW.H., MurdingerF.A., GugelB.. Bone mineral density after kidney transplantation. A cross-sectional study in 190 graft Recipients up to 20 years after transplantation.Transplantation1995; 59(7): 982–6.
9.
GrotzW.H., MundingerF.A., GugelB.. Bone fracture and osteodensitometry with dual energy X-ray absorptiometry in kidney transplant recipients.Transplantation1994; 58(8): 912–5.
LyhneN., PedersenF.B.. Changes in bone mineral content during long-term CAPD. Indication of a sex-dependent bone mineral loss.Nephrol Dial Transplant1995; 10(3): 395–8.
12.
HardyP., BenoitJ.. Donneaud B, Jehano P, Lortat AJ. Pathological fractures in the femoral neck in hemodialyzed patients. A propos of 26 cases.Rev Chir Orthop Reparatrice Appar Mot1994; 80(8): 702–10.
13.
CooperC., CampionG., MeltonLJ3rd. Hip fractures in the elderly: a world-wide projection.Osteoporosis Int1992; 2(6): 285–9.
14.
JohnellO., GulbergB., AllanderE., KanisJ.A.. The apparent incidence of hip fracture in Europe: a study of national register sources. MEDOS Study Group.Osteoporosis Int1992; 2(6) 298–302.
15.
O'NeilT.W., VarlowJ., FelsenbergD.. Variation in vertebral height ratios in population studies. European Vertebral Osteoporosis Study Group.J Bone Miner Res1994; 9(12): 1895–1907.
16.
GuzzardellaG-A, FiniM., GiavaresiG., MorroneG., OrientiL., GiardinoR.. II processo di osteointegrazione: un capitolo ancora aperto della ricerca sperimentale e clinica.Acta Biomed Ateneo Parmense1996; 67(1/2): 55–60.
17.
Le GerosR.Z., CraigR.G.. Strategies to affect bone remodelling: osteointegration.J Bone Miner Res1993; 8(suppl) 2: S583–96.
18.
SmithD.C.. Surface characterisation of implant materials: biological implications. In: Davies, ed. The bone biomaterial interface, Davies ED.University of Toronto Press, 1991.
19.
KohnD.H.. Overview of factors important in implant design.J Oral Implantology1992; 18(3): 204–19.
20.
GnudiS., GiardinoR., MongiorgiR.. Evaluation of an experimental model of osteoporosis induced in the female rat through ovariectomy.Boll Soc Ital Biol Sper1993; 69(7-8): 461–8.
21.
ToriyamaM., RavaglioliA., KrajewskiA.. Slip casting of mechanochemically synthesized hydroxyapatite.Journal of Materials Science1995; 30: 3216–21.
22.
FiniM., RavaglioliA., KrajewskiA.. Experimental in vivo investigation on hydroxyapatite with high mechanical properties.Int J Artif Organs1994; 17(8): 431.
23.
ToriyamaM., RavaglioliA., KrajewskiA., CelottiG., PiancastelliA.. Synthesis of hydroxyapatite-based powders by mechanochemical method and their sintering.Journal of the European Ceramic society1996; 16: 429–36.
24.
ZwickerH.U., SchmidH.J.. Mechanical properties of metallic materials for long term use in highly stressed locomotor system. In: SchaldachM., HobinanD., eds. Artificial Hip and KneeJoint Technology1976; 258–72.
25.
ISO 10993-6: 1994 (E).Biological evaluation of medical device.Part 6: Tests for local effects after implantation.
26.
SennerbyL., ThomsenP.. Tissue response to titanium implants in experimental antigen-induced arthritis.Biomaterials1993; 14(6): 413–22.
27.
HayashiK., UenoyamaK., MatsuguchiN., NakagawaS., SugiokaY.. The affinity of bone to Hydroxyapatite and Alumina in experimentally induced osteoporosis.J Arthroplasty1989; 4(3): 256–62.
28.
HayashiK., UenoyamaK., MashimaT., SugiokaY.. Remodelling of bone around hydroxyapatite and titanium in experimental osteoporosis.Biomaterials1994; 15(1): 11–6.
29.
KhoslaS., Joseph MeltonL.III. Secondary osteoporosis. In: Lawrence RiggsB., Joseph MeltonI.I.I., eds. Osteoporosis. Etiology, Diagnosis and Management.Philadelphia, New York: Lippincott-Raven,1995; 183: 204.
30.
MoroniA., OrientiL., SteaS., VisentinM.. Improvement of the bone-pin interface with hydroxyapatite coating: an in vivo long term experimental study.J Orthop Trauma1996; 4: 236–42.
31.
CarlssonL., RostrlundT., AlbrektssonB., AlbrektssonT.. Removal torques for polished and rough titanium implants.Int J Oral Maxillofac Surg1988; 3(1): 21–4.
32.
ThompsonD.D., SimmonsH.A., PirieC.M., KeH.Z.. FDA guidelines and animal models for osteoporosis.Bone1995; 17(suppl) 4: S125–33.
33.
Draft. Guidelines for preclinical and clinical evaluations of agents used in the prevention or treatment of post-menopausal osteoporosis. Division of Metabolism and Endocrine Drug Products.Food and Drug Administration, April 1994.
34.
JablonskiG., MortensenB.M., KlemK.H.. Vitamin D3 analogs and salmon calcitonin partially reverse the development of renal osteodystrophy in rats.Calcif Tissue Int1995; 57(5): 385–91.
35.
Naveh-ManyT., RahamimovR., LivniN., SilverJ.. Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D.J Clin Invest1995; 96(4): 1786–93.
36.
NewmanE., TurnerA.S., WarkJ.D.. The potential of sheep for the study of osteopenia: current status and comparison with other animal models.Bone1995; 16(suppl) 4: S277–84.
37.
TurnerA.S., EckofD.G., AlvisM.R., VillanuevaA.R., AbermanH.M.. Failure of hydroxylapatite coating to promote biologic fixation in an estrogen-deficient model. Presented at the 42nd Annual Meeting of the Orthopaedic Research Society, Atlanta, February 1996.
